-
Breakaway king Simmons escapes with win at Tour Auvergne-Rhone-Alpes
-
Belfast girds for more violence after stabbing suspect held
-
Juve, Torino fans given 10-match away ban after derby trouble: media
-
Stocks slide as US inflation surges, US and Iran trade strikes
-
Surging US consumer inflation hits three-year high in key challenge for Trump
-
Vaughan backs Stokes to stay on as England captain
-
Bill Gates arrives for questioning in US Congress over Epstein ties
-
Amnesty accuses Israel of 'ethnic cleansing' of West Bank Bedouins
-
German consortium hopes to build new fighter jet after FCAS collapse
-
O'Callaghan and Short clock history-making times at Australian trials
-
Trump says Iran 'taken too long to negotiate,' will have to 'pay the price'
-
Pakistan launches deadly strikes on Afghanistan
-
Israel's Netanyahu to seek re-election despite Trump doubts, war strains
-
Stocks drop ahead of key US inflation data
-
6-7, Bad Bunny, AI: Pope targets the young
-
FIFA boss Infantino faces questions on eve of World Cup
-
Iran attacks US bases in Jordan and Bahrain
-
Tech leads Asia losses as rollercoaster week rumbles on
-
Belfast stabbing suspect due in court after night of violence
-
Saudi's new national carrier gets off ground despite war, delays
-
Eddie Jones eyes Mourinho-like laundry stunt to escape ban
-
Bollywood's Imtiaz Ali bets on Gen Z thirst for love
-
Messi plushies see roaring trade as China firms get World Cup boost
-
Messi sparkles on return as Somali referee says World Cup dream over
-
Iran, US trade blows as Middle East peace deal draws no nearer
-
Salt: integral ingredient of sumo stars' art
-
Staal shines as Carolina beat Vegas 5-3 to level Stanley Cup Final
-
Messi scores on injury return as Argentina beat Iceland in World Cup warm-up
-
Art, maths and killing: Ukraine drone chief's formula to stop Russia
-
Tech leads Asia losses, oil rises as rollercoaster week rumbles on
-
Messi set to return as Somali referee says World Cup dream over
-
Former Wallabies skipper Wright signs for Welsh club Ospreys
-
Pope to bless Barcelona's Sagrada Familia, world's tallest church
-
Emotional World Cup return to Mexico for South Africa coach Broos
-
Bill Gates faces questioning in US Congress over Epstein ties
-
'The Donald of Dubai': property tycoon seeks to become data king
-
PGA Tour to co-sanction Australian Open in global push
-
Elon Musk, after DOGE and politics, bets on SpaceX IPO
-
Saudis in World Cup spotlight after $2bn spending spree
-
Mexico doubles down on security before 2026 World Cup
-
US must not be 'too honest' at World Cup, says Roldan
-
Italian astronaut to pilot Artemis III mission
-
North Korea says Xi's visit produced 'far-reaching blueprint' for ties
-
Benfica say farewell to Mourinho as Real Madrid return nears
-
Protesters torch buildings and vehicles, block roads over Belfast stabbing
-
US strikes Iran after Apache helicopter downing
-
Threats to US lawmakers spiked after Meta eased moderation: watchdog
-
Nick Reiner seeks trust fund money for parent murder defense
-
Spain, France qualify for 2027 Women's World Cup as England wait
-
Protesters torch building and vehicles, block roads over Belfast stabbing
First Covid vaccine side-effect claims land in German courts
Vaccine-maker BioNTech faced Monday its first legal claim in its home country of Germany over adverse effects allegedly suffered by some users of its Covid vaccines, more than two years after one of the world's fastest and most extensive inoculation campaigns.
In the face of the deadly pandemic that emerged in early 2020, which prompted border closures and lockdowns that trapped millions of people in their homes, the arrival of Covid vaccines had been widely hailed as a life-saver.
But the jabs, which had been developed at breakneck speed and granted early approval for usage, are now the focus of legal procedures in several countries including France and Britain where plaintiffs argue that the vaccines harmed their health.
In Germany, a court in Hamburg was prepared to hear a case from Monday against BioNTech, which, together with US giant Pfizer, produced the first mRNA vaccine Comirnaty.
The hearing was delayed however after the claimant's lawyers put in a last-minute challenge of the judge's impartiality, and asking instead for a panel of judges to rule on the case.
In her claim, the plaintiff reported suffering effects including "pain in the upper body, swelling of the extremities, exhaustion, fatigue and sleeping disorders" after receiving the vaccine, the court said.
She is seeking 150,000 euros ($162,000) in damages and recognition that the "defendant is bound to provide material damages", the court added.
Her lawyer Thomas Ulbrich, who is also representing another 250 people in similar cases, said his clients were "all healthy" before suffering from symptoms, allegedly following their jabs.
He believes that the medical files he has on hand offer a link between the vaccines and the symptoms experienced by his clients.
- 'Rocky and long road' -
BioNTech's mRNA vaccine, a scientific breakthrough, had been granted conditional marketing authorisation as early as December 21, 2020, by the EU regulatory authority EMA.
Similar authorisation for Moderna, another mRNA vaccine maker, swiftly followed.
With fears of catching the disease running high, the vaccines were pre-ordered by governments even during their development phases, and deployment swiftly followed once regulatory authorities gave their approval.
But the new generation of inoculations also sparked a wave of vaccine sceptics questioning the safety of the jabs.
Out of 192 million jabs given in Germany, the country's medicines regulator, the Paul Ehrlich Institute, said 338,857 suspected cases of side effects were reported, including 54,879 severe reactions.
Among the worst cases, "the symptoms are very different, they vary from stroke to thrombosis to cardiac diseases", said another German lawyer, Joachim Caesar-Preller, who represents 140 clients making similar claims.
He is seeking up to one million euros in damages per case -- plus interest -- but concedes that a "rocky and long road" lies ahead in the legal battles.
- 'Not an isolated case' -
A key point for the courts is whether the side effects of the medication, when used correctly, surpass "a justifiable level according to the findings of medical science".
In other words, the effects have to be sufficiently serious to be taken into account, said Anatol Dutta, a professor at Munich University.
A claimant identified only as Kathrin K., 45, believes her symptoms are severe enough.
She said she lost a lot of weight after taking the vaccine and had to undergo several intestinal operations.
"I hate it when people tell me that I'm an isolated case," she said. "I'm not."
To address the question of causality, the courts would likely have to obtain expert advice.
Besides the legal avenue, claimants can also turn to the state for compensation for the loss of income.
More than 8,000 such applications had been made as of April, and so far about five percent have been successful, according to German media.
BioNTech told AFP that the number of liability claims made to the company is very small when compared to the number of doses it has delivered worldwide, and that each claim had to be examined individually.
"Justified liability claims would of course be met by BioNTech," it said, adding however that "no causal relationship between (the) health impairments presented and vaccination with Comirnaty has been proven" in the cases it had reviewed so far.
Another lawyer, Anja Dornhoff, advises her clients to establish a chronology and to get medical practitioners to document the development of their symptoms.
"I hope that people with post-vaccination syndromes can be taken seriously," she said.
J.AbuHassan--SF-PST